Cited by 9,709Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionEconomic and Financial Impacts of Cancer

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Cancer Statistics, 2009

Open access

Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Thun, M. J.·2009·CA: A Cancer Journal for Clinicians

DOI 10.3322/caac.20006

Open this paper in CoChat — free account

Abstract

Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Incidence and death rates are standardized by age to the 2000 United States standard million population. A total of 1,479,350 new cancer cases and 562,340 deaths from cancer are projected to occur in the United States in 2009. Overall cancer incidence rates decreased in the most recent time period in both men (1.8% per year from 2001 to 2005) and women (0.6% per year from 1998 to 2005), largely because of decreases in the three major cancer sites in men (lung, prostate, and colon and rectum [colorectum]) and in two major cancer sites in women (breast and colorectum). Overall cancer death rates decreased in men by 19.2% between 1990 and 2005, with decreases in lung (37%), prostate (24%), and colorectal (17%) cancer rates accounting for nearly 80% of the total decrease. Among women, overall cancer death rates between 1991 and 2005 decreased by 11.4%, with decreases in breast (37%) and colorectal (24%) cancer rates accounting for 60% of the total decrease. The reduction in the overall cancer death rates has resulted in the avoidance of about 650,000 deaths from cancer over the 15-year period. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, education, geographic area, and calendar year. Although progress has been made in reducing incidence and mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons younger than 85 years of age. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population and by supporting new discoveries in cancer prevention, early detection, and treatment.

Integrity signals

Registry

Crossref · 10.3322/caac.20006

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cancer Disparities by Race/Ethnicity and Socioeconomic Status
Ward, E., Jemal, A., Cokkinides, V. E., Singh, G. K., Cardinez, C. J., Ghafoor, A., & Thun, M. J. (2004) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.78 · Cited by 1,796
Self-citation
Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival
Jemal, A., Clegg, L. X., Ward, E., Ries, L. A. G., Wu, X., Jamison, P. M., Wingo, P. A., Howe, H. L., Anderson, R. N., & Edwards, B. K. (2004) · Cancer · doi:10.1002/cncr.20288 · Cited by 1,141
Self-citation
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 981
Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control
Jemal, A., Thun, M. J., Ries, L. A. G., Howe, H. L., Weir, H. K., Ward, E., Wu, X., Eheman, C. R., Anderson, R. N., Ajani, U. A., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn389 · Cited by 961
Self-citation
Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives
Espey, D. K., Wu, X., Swan, J., Wiggins, C. L., Jim, M. A., Ward, E., Wingo, P. A., Howe, H. L., Ries, L. A. G., Miller, B. A., et al. (2007) · Cancer · doi:10.1002/cncr.23044 · Cited by 578
Self-citation
Cancer Statistics for African Americans
Ghafoor, A., Jemal, A., Cokkinides, V. E., Cardinez, C. J., Murray, T., Samuels, A., & Thun, M. J. (2002) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.326 · Cited by 549
Self-citation
Cancer Survival Among US Whites and Minorities
Clegg, L. X., Li, F. P., Hankey, B. F., Chu, K. C., & Edwards, B. K. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.17.1985 · Cited by 535
Survival of Blacks and Whites After a Cancer Diagnosis
Bach, P. B. (2002) · JAMA · doi:10.1001/jama.287.16.2106 · Cited by 514
Trends in Breast Cancer by Race and Ethnicity
Ghafoor, A., Jemal, A., Ward, E., Cokkinides, V. E., Smith, R. A., & Thun, M. J. (2003) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.6.342 · Cited by 450
Self-citation
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women
Jemal, A., Ward, E., & Thun, M. J. (2007) · Breast Cancer Research · doi:10.1186/bcr1672 · Cited by 353
Self-citation

Flagged first, then by citations

Show all 15 references

Sorted by citations

Items 601–700 of 1,041

Surgery improves pain, function and quality of life in patients with spinal metastases: a prospective study on 118 patients
Quan, G. M. Y., Vital, J.-M., Aurouer, N., Obeid, I., Palussière, J., Diallo, A., & Pointillart, V. (2011) · European Spine Journal · doi:10.1007/s00586-011-1867-6 · Cited by 158
EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors
Pallis, A. G., Ring, A. E., Fortpied, C., Penninckx, B., Nes, M.-C. V., Wedding, U., vonMinckwitz, G., Johnson, C. D., Wyld, L., Timmer-Bonte, A., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq687 · Cited by 158
A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi
Hoogeboom, R., van Kessel, K. P. M., Hochstenbach, F., Wormhoudt, T. A. M., Reinten, R. J. A., Wagner, K., Kater, A. P., Guikema, J. E. J., Bende, R. J., & van Noesel, C. J. M. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121801 · Cited by 158
Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer
Sun, J., Huang, J., Lan, J., Zhou, K., Gao, Y., Song, Z., Deng, Y., Liu, L., Dong, Y., & Liu, X. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0986-8 · Cited by 158
Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro
Yang, L., Wu, X., Wang, D., LUO, C.-L., & Chen, L. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1634 · Cited by 157
Cellular Plasticity within the Pancreas— Lessons Learned from Development
Puri, S., & Hebrok, M. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.02.005 · Cited by 161
Pulmonary Lesion Assessment: Comparison of Whole-Body Hybrid MR/PET and PET/CT Imaging—Pilot Study
Schwenzer, N. F., Schraml, C., Müller, M., Brendle, C., Sauter, A. W., Spengler, W., Pfannenberg, A. C., Claussen, C. D., & Schmidt, H. (2012) · Radiology · doi:10.1148/radiol.12111942 · Cited by 157
Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland
Gier, B., Butler, P. C., Lai, C. K., Kirakossian, D., DeNicola, M. M., & Yeh, M. W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2407 · Cited by 157
Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies
Sanna, V., Roggio, A. M., Posadino, A. M., Cossu, A., Marceddu, S., Mariani, A., Alzari, V., Uzzau, S., Pintus, G., & Sechi, M. (2011) · Nanoscale Research Letters · doi:10.1186/1556-276x-6-260 · Cited by 157
Biology of Colorectal Cancer
Saif, M. W., & Chu, E. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181e076af · Cited by 154
Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome
Kim, S. M., Park, Y.-Y., Park, E. S., Choi, Y., Izzo, J. G., Zhang, D., Kim, S.-B., Lee, J. H., Bhutani, M. S., Swisher, S. G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015074 · Cited by 156
Do Surgical Margin and Local Recurrence Influence Survival in Soft Tissue Sarcomas?
Novais, E. N. V., Demiralp, B., Alderete, J. F., Larson, M. C., Rose, P. S., & Sim, F. H. (2010) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-010-1471-9 · Cited by 156
Advanced gastric cancer – Slow but steady progress
Power, D. G., Kelsen, D. P., & Shah, M. A. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.01.005 · Cited by 156
The identification of an ESCC susceptibility SNP rs920778 that regulates the expression of lncRNAHOTAIRvia a novel intronic enhancer
Zhang, X., Zhou, L., Fu, G., Sun, F. Y., Shi, J., Wei, J., Lu, C. T., Zhou, C., Yuan, Q., & Yang, M. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu103 · Cited by 156
Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer
Schauer, I. G., Sood, A. K., Mok, S. C., & Liu, J. (2011) · Neoplasia · doi:10.1593/neo.101720 · Cited by 167
Non‐invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification system
Miyamoto, H., Miller, J. S., Fajardo, D. A., Lee, T. K. M., Netto, G. J., & Epstein, J. I. (2009) · Pathology International · doi:10.1111/j.1440-1827.2009.02477.x · Cited by 155
Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts
Hilchie, A. L., Doucette, C. D., Pinto, D. M., Patrzykat, A., Douglas, S. E., & Hoskin, D. W. (2011) · Breast Cancer Research · doi:10.1186/bcr3043 · Cited by 156
Number of Metastatic Lymph Nodes, but Not Lymph Node Ratio, Is an Independent Prognostic Factor after Resection of Pancreatic Carcinoma
Murakami, Y., Uemura, K., Sudo, T., Hayashidani, Y., Hashimoto, Y., Nakashima, A., Yuasa, Y., Kondo, N., Ohge, H., & Sueda, T. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2010.03.037 · Cited by 155
Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer
Salcido, C. D., Larochelle, A., Taylor, B. J., Dunbar, C. E., & Varticovski, L. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605668 · Cited by 153
Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial
for the Dutch Pancreatic Cancer Group (DPCG), Versteijne, E., van Eijck, C. H. J., Punt, C. J. A., Suker, M., Zwinderman, A. H., Dohmen, M. A. C., Groothuis, K., Busch, O. R. C., Besselink, M. G., et al. (2016) · Trials · doi:10.1186/s13063-016-1262-z · Cited by 155
Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy
Fujita, H., Ohuchida, K., Mizumoto, K., Itaba, S., Ito, T., Nakata, K., Yu, J., Kayashima, T., Souzaki, R., Tajiri, T., et al. (2010) · Neoplasia · doi:10.1593/neo.10458 · Cited by 154
Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
Taneja, P., Maglic, D., Kai, F., Zhu, S., Kendig, R. D., Elizabeth, A., & Inoue, K. (2010) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s4773 · Cited by 160
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer
Paik, J. H., Choi, C., Kim, H., Jang, S. J., Choe, G., Kim, D. K., Kim, H. J., Yoon, H.-I., Lee, C., Jheon, S., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.11.008 · Cited by 154
Pump-Probe Imaging Differentiates Melanoma from Melanocytic Nevi
Matthews, T. E., Piletic, I. R., Selim, M. A., Simpson, M. J., & Warren, W. S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001604 · Cited by 154
A survey of Internet utilization among patients with cancer
Castleton, K. B., Fong, T., Wang‐Gillam, A., Waqar, M. A., Jeffe, D. B., Kehlenbrink, L., Gao, F., & Govindan, R. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0935-5 · Cited by 154
Pesticide Use and Cutaneous Melanoma in Pesticide Applicators in the Agricultural Heath Study
Dennis, L. K., Lynch, C. F., Sandler, D. P., & Alavanja, M. C. R. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901518 · Cited by 162
Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: A randomized clinical trial
Fedirko, V., Bostick, R. M., Long, Q., Flanders, W. D., McCullough, M. L., Sidelnikov, E., Daniel, C. R., Rutherford, R. E., & Shaukat, A. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0448 · Cited by 150
The Kynurenine Pathway in Brain Tumor Pathogenesis
Adams, S., Braidy, N., Bessesde, A., Brew, B. J., Grant, R., Teo, C., & Guillemin, G. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0549 · Cited by 157
The human protein atlas
Navani, S. (2011) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-011-0013-z · Cited by 153
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism
Sureban, S. M., May, R. J., Mondalek, F. G., Qu, D., Ponnurangam, S., Pantazis, P., Anant, S., Ramanujam, R. P., & Houchen, C. W. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-40 · Cited by 153
Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol
Melkamu, T., Zhang, X., Tan, J., Zeng, Y., & Kassie, F. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp208 · Cited by 152
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non–Small Cell Lung Cancer Growth and Metastasis
Preet, A., Qamri, Z., Nasser, M. W., Prasad, A., Shilo, K., Zou, X., Groopman, J. E., & Ganju, R. K. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0181 · Cited by 156
Novel Clues on the Specific Association of Streptococcus gallolyticus subsp gallolyticus With Colorectal Cancer
Boleij, A., Muytjens, C. M. J., Bukhari, S. I., Cayet, N., Glaser, P., Hermans, P. W. M., Swinkels, D. W., Bolhuis, A., & Tjalsma, H. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq169 · Cited by 153
Phase I Clinical Study of Seneca Valley Virus (SVV-001),a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features
Rudin, C. M., Poirier, J. T., Senzer, N. N., Stephenson, J., Loesch, D. M., Burroughs, K. D., Reddy, P. S., Hann, C. L., & Hallenbeck, P. L. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1706 · Cited by 153
Immunosuppressive Effects of Multiple Myeloma Are Overcome by PD-L1 Blockade
Hallett, W. H. D., Jing, W., Drobyski, W. R., & Johnson, B. D. (2011) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2011.03.011 · Cited by 152
A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer
Martín, M., Bonneterre, J. M., Geyer, C. E., Ito, Y., Ro, J., Láng, I., Kim, S., Germa, C., Vermette, J. J., Wang, K., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.07.142 · Cited by 152
Sox2 Protein Expression is an Independent Poor Prognostic Indicator in Stage I Lung Adenocarcinoma
Sholl, L. M., Barletta, J. A., Yeap, B. Y., Chirieac, L. R., & Hornick, J. L. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181e5e024 · Cited by 152
Strategies for Cancer Vaccine Development
Vergati, M., Intrivici, C., Huen, N., Schlom, J., & Tsang, K. Y. (2010) · BioMed Research International · doi:10.1155/2010/596432 · Cited by 155
Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer
Pruthi, S., Gostout, B. S., & Lindor, N. M. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0414 · Cited by 161
Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
Han, Y. D., Oh, T. J., Chung, T., Jang, H. W., Kim, Y. N., An, S., & Kim, N. K. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0642-0 · Cited by 152
The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF- B/Snail/RKIP/PTEN Circuit
Lin, K., Baritaki, S., Militello, L., Malaponte, G., Bevelacqua, Y., & Bonavida, B. (2010) · Genes & Cancer · doi:10.1177/1947601910373795 · Cited by 150
Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma
Prickett, T. D., Wei, X., Cárdenas-Navia, I., Teer, J. K., Lin, J., Walia, V., Gartner, J. J., Jiang, J., Cherukuri, P. F., Molinolo, A. A., et al. (2011) · Nature Genetics · doi:10.1038/ng.950 · Cited by 150
TGF-β Signaling Alterations and Colon Cancer
Bellam, N., & Pasche, B. (2010) · Cancer treatment and research · doi:10.1007/978-1-4419-6033-7_5 · Cited by 158
Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation
Shi, J., Sun, B., Shi, W., Zuo, H., Cui, D., Ni, L., & Chen, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2644-z · Cited by 163
FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1
Pchejetski, D., Böhler, T., Brizuela, L., Sauer, L., Doumerc, N., Golzio, M., Salunkhe, V. A., Teissié, J., Malavaud, B. A., Waxman, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1388 · Cited by 150
Effects of Fruit Ellagitannin Extracts, Ellagic Acid, and Their Colonic Metabolite, Urolithin A, on Wnt Signaling
Sharma, M., Li, L., Celver, J. P., Killian, C., Kovoor, A., & Seeram, N. P. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf902857v · Cited by 150
Quantification of the thermal signature of a melanoma lesion
Çetingül, M. P., & Herman, Č. (2010) · International Journal of Thermal Sciences · doi:10.1016/j.ijthermalsci.2010.10.019 · Cited by 150
Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases
Kulda, V., Pešta, M., Topolčan, O., Liška, V., Třeška, V., Sutnar, A., Rupert, K., Ludvíková, M., Babuška, V., Holubec, L., et al. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.04.015 · Cited by 154
Expression of microRNAs in the Urine of Patients With Bladder Cancer
Wang, G., Chan, E., Kwan, B. C., Li, P. K., Yip, S. K., Szeto, C., & Ng, C. (2012) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2012.01.001 · Cited by 149
EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice
Gahr, S., Stoehr, R., Geissinger, E., Ficker, J. H., Brueckl, W. M., Gschwendtner, A., Gattenloehner, S., Fuchs, F. S., Schulz, C. K. J., Rieker, R. J., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.511 · Cited by 150
Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells
Hessvik, N. P., Phuyal, S., Brech, A., Sandvig, K., & Llorente, A. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.08.016 · Cited by 150
Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms
Maurya, D. K., Nandakumar, N., & Devasagayam, T. P. A. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-004fr · Cited by 149
Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer
Zhu, W., He, J.-Y., Chen, D., Zhang, B., Xu, L., Ma, H., Liu, X., Zhang, Y., & Le, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087780 · Cited by 149
Clinicopathological Features of Homologous Recombination–Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival
Mukhopadhyay, A., Plummer, E. R., Elattar, A., Soohoo, S., Uzir, B. F., Quinn, J. E., McCluggage, W. G., Maxwell, P., Aneke, H., Curtin, N. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0324 · Cited by 151
Distinct clinical features and outcomes in never‐smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement
Kim, H. R., Shim, H. S., Chung, J.-H., Lee, Y. J., Hong, Y. K., Rha, S. Y., Kim, S. H., Ha, S., Kim, S. K., Chung, K. S., et al. (2011) · Cancer · doi:10.1002/cncr.26311 · Cited by 149
Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements
Hayes, D. N., Lucas, A. S., Tanvetyanon, T., Krzyzanowska, M. K., Chung, C. H., Murphy, B. A., Gilbert, J., Mehra, R., Moore, D. T., Sheikh, A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0563 · Cited by 154
Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
Ferdinande, L., Decaestecker, C., Verset, L., Mathieu, A., Lopez, X. M., Negulescu, A.-M., Maerken, T. V., Salmon, I. J., Cuvelier, C. A., & Demetter, P. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.513 · Cited by 153
Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?
Borden, K. L. B., & Čuljković, B. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.496506 · Cited by 159
Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis
Guo, L., Liu, Y., Bai, Y., Sun, Y., Xiao, F.-M., & Guo, Y. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.043 · Cited by 151
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
Chang, J. Y., Liu, H., Balter, P. A., Komaki, R. R., Liao, Z. X., Welsh, J. W., Mehran, R. J., Roth, J. A., & Swisher, S. G. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-152 · Cited by 148
Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development
Zhang, S., Hao, J., Xie, F., Hu, X., Liu, C., Tong, J., Zhou, J., Wu, J., & Shao, C. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr105 · Cited by 148
Clear Cell Renal Cell Carcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis for Prediction of Fuhrman Nuclear Grade
Bektaş, C. T., Koçak, B., Yardımcı, A. H., Türkcanoğlu, M. H., Yücetaş, U., Koca, S. B., Erdim, Ç., & Kılıçkesmez, Ö. (2018) · European Radiology · doi:10.1007/s00330-018-5698-2 · Cited by 151
Peyronie's disease following radical prostatectomy: incidence and predictors.
Tal, R., Heck, M., Teloken, P., Siegrist, T., Nelson, C., & Mulhall, J. (2010) · Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01655.x · Cited by 151
Surgical outcomes of robotic-assisted surgical staging for endometrial cancer are equivalent to traditional laparoscopic staging at a minimally invasive surgical center
Cardenas-Goicoechea, J., Adams, S. F., Bhat, S. B., & Randall, T. C. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.01.009 · Cited by 147
Targeting Apoptosis Pathway with Natural Terpenoids: Implications for Treatment of Breast and Prostate Cancer
Yang, H., & Dou, Q. P. (2010) · Current Drug Targets · doi:10.2174/138945010791170842 · Cited by 148
Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer
Boleij, A., & Tjalsma, H. (2012) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2012.00218.x · Cited by 153
Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
Brown, K. C. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790963788 · Cited by 146
Secreted Hsp90 Is a Novel Regulator of the Epithelial to Mesenchymal Transition (EMT) in Prostate Cancer
Hance, M. W., Dole, K., Gopal, U., Bohonowych, J. E. S., Jezierska‐Drutel, A., Neumann, C. A., Liu, H., Garraway, I. P., & Isaacs, J. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.389015 · Cited by 147
Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality
Muñoz, D. F., Near, A. M., van Ravesteyn, N. T., Lee, S. J., Schechter, C. B., Alagöz, O., Berry, D. A., Burnside, E. S., Chang, Y.-J., Chisholm, G. B., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju289 · Cited by 146
Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway
Lin, C.-H., Chang, C.-Y., Lee, K., Lin, H.-J., Chen, T.-H., & Wan, L. (2015) · BMC Cancer · doi:10.1186/s12885-015-1965-7 · Cited by 153
Sipuleucel-T
Higano, C. S., Small, E. J., Schellhammer, P. F., Yasothan, U., Gubernick, S. I., Kirkpatrick, P. N., & Kantoff, P. W. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3220 · Cited by 147
Role of Hyaluronan-Mediated CD44 Signaling in Head and Neck Squamous Cell Carcinoma Progression and Chemoresistance
Wang, S. J., & Bourguignon, L. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.077 · Cited by 146
The Role of M1 and M2 Macrophages in Prostate Cancer in relation to Extracapsular Tumor Extension and Biochemical Recurrence after Radical Prostatectomy
Lanciotti, M., Masieri, L., Raspollini, M. R., Minervini, A., Mari, A., Comito, G., Giannoni, E., Carini, M., Chiarugi, P., & Serni, S. (2014) · BioMed Research International · doi:10.1155/2014/486798 · Cited by 146
Direct and Buffering Effects of Social Support Among Gynecologic Cancer Survivors
Carpenter, K. M., Fowler, J. M., Maxwell, G. L., & Andersen, B. L. (2010) · Annals of Behavioral Medicine · doi:10.1007/s12160-010-9160-1 · Cited by 157
Microscopic Margins and Patterns of Treatment Failure in Resected Pancreatic Adenocarcinoma
Gnerlich, J. L., Luka, S., Deshpande, A. D., DuBray, B. J., Weir, J. S., Carpenter, D. H., Brunt, E. M., Strasberg, S. M., Hawkins, W. G., & Linehan, D. C. (2012) · Archives of Surgery · doi:10.1001/archsurg.2012.1126 · Cited by 146
Tumor Transcriptome Sequencing Reveals Allelic Expression Imbalances Associated with Copy Number Alterations
Tuch, B. B., Laborde, R. R., Xu, X. J., Gu, J. H., Chung, C. B., Monighetti, C. K., Stanley, S. J., Olsen, K. D., Kasperbauer, J. L., Moore, E. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009317 · Cited by 150
Docetaxel-based combination therapy for castration-resistant prostate cancer
Galsky, M. D., & Vogelzang, N. J. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq050 · Cited by 146
Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells
Watson, J. L., Hill, R., Yaffe, P. B., Greenshields, A. L., Walsh, M. J., Lee, P. W. K., Giacomantonio, C. A., & Hoskin, D. W. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.018 · Cited by 148
Antitumor Activity of Chinese Propolis in Human Breast Cancer MCF‐7 and MDA‐MB‐231 Cells
Xuan, H., Li, Z., Yan, H., Sang, Q., Wang, K., He, Q., Wang, Y., & Hu, F. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/280120 · Cited by 145
Toll-like receptor signaling in colorectal cancer: Carcinogenesis to cancer therapy
Li, T., Ogino, S., & Qian, Z. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17699 · Cited by 145
Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
Ning, Y. M., Gulley, J. L., Arlen, P. M., Woo, S., Steinberg, S. M., Wright, J. J., Parnes, H. L., Trepel, J. B., Lee, M.-J., Kim, Y. S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4524 · Cited by 145
Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer
Taeger, J., Moser, C., Hellerbrand, C., Mycielska, M. E., Glockzin, G., Schlitt, H. J., Geissler, E. K., Stoeltzing, O., & Lang, S. A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0312 · Cited by 148
Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care
Stitzenberg, K. B., Wong, Y., Nielsen, M. E., Egleston, B. L., & Uzzo, R. G. (2011) · Cancer · doi:10.1002/cncr.26274 · Cited by 144
Impact of delay in diagnosis on survival to head and neck carcinomas: a systematic review with meta‐analysis
Seoane, J., Takkouche, B., Varela‐Centelles, P. I., Tomás, I., & Romero, J. M. (2012) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2012.02464.x · Cited by 144
Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
Patel, V., Marsh, C. A., Dorsam, R. T., Mikelis, C. M., Masedunskas, A., Amornphimoltham, P., Nathan, C. O., Singh, B., Weigert, R., Molinolo, A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3192 · Cited by 144
DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer
Sureban, S. M., May, R. J., Qu, D., Weygant, N., Chandrakesan, P., Ali, N., Lightfoot, S. A., Pantazis, P., Rao, C. V., Postier, R. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073940 · Cited by 144
miRNA Expression in Colon Polyps Provides Evidence for a Multihit Model of Colon Cancer
Oberg, A. L., French, A. J., Sarver, A. L., Subramanian, S., Morlan, B. W., Riska, S. M., Borralho, P. M., Cunningham, J. M., Boardman, L. A., Wang, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020465 · Cited by 142
Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens
Friedrich, M., Raum, T., Lutterbuese, R., Voelkel, M., Deegen, P., Rau, D., Kischel, R., Hoffmann, P., Brandl, C., Schuhmacher, J., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0042 · Cited by 145
Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer.
Sun, S., Liu, P., Shao, F.-M., & Miao, Q. (2015) · PubMed Central · Cited by 144
TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
Wang, X., Sun, D., Tai, J., Chen, S., Yu, M., Ren, D., & Wang, L. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0683-9 · Cited by 144
Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S. - a SEER analysis
Kakarala, M., Rozek, L. S., Coté, M. L., Liyanage, S., & Brenner, D. E. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-191 · Cited by 144
Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710)
Scosyrev, E., Ely, B., Messing, E. M., Speights, V. O., Grossman, H. B., Wood, D. P., White, R. D., Vogelzang, N. J., Trump, D. L., Natale, R. B., et al. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09900.x · Cited by 143
Papillary carcinoma of the breast: an overview
Pal, S. K., Lau, S. K., Kruper, L. L., Nwoye, U. O., Garberoglio, C. A., Gupta, R. K., Paz, B. I., Vora, L., Guzman, E. A., Artinyan, A., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0961-5 · Cited by 143
Review: Green Tea Polyphenols in Chemoprevention of Prostate Cancer: Preclinical and Clinical Studies
Khan, N., Adhami, V. M., & Mukhtar, H. (2009) · Nutrition and Cancer · doi:10.1080/01635580903285056 · Cited by 143
The top-cited research works in the Science Citation Index Expanded
Ho, Y. (2012) · Scientometrics · doi:10.1007/s11192-012-0837-z · Cited by 143
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Wagener, N., Macher‐Goeppinger, S., Pritsch, M., Hüsing, J., Hoppe‐Seyler, K., Schirmacher, P., Pfitzenmaier, J., Haferkamp, A., Hoppe‐Seyler, F., & Hohenfellner, M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-524 · Cited by 147
Targeting apoptosis pathways in pancreatic cancer
Arlt, A., Müerköster, S. S., & Schäfer, H. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.10.015 · Cited by 143
Quality of life assessment as a predictor of survival in non-small cell lung cancer
Braun, D. P., Gupta, D., & Staren, E. D. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-353 · Cited by 143
MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis
Nakata, K., Ohuchida, K., Mizumoto, K., Kayashima, T., Ikenaga, N., Sakai, H., Cui, L., Fujita, H., Otsuka, T., Aishima, S., et al. (2011) · Surgery · doi:10.1016/j.surg.2011.06.017 · Cited by 143
β-Lapachone Micellar Nanotherapeutics for Non–Small Cell Lung Cancer Therapy
Blanco, E., Bey, E. A., Khemtong, C., Yang, S.-G., Guthi, J. S., Chen, H., Kessinger, C. W., Carnevale, K. A., Bornmann, W. G., Boothman, D. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3995 · Cited by 143

Authors: Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J.
Affiliations: American Cancer Society (US)
Centers for Disease Control and Prevention (US)
ORCID: Jemal, A.
Siegel, R.
Ward, E.
Xu, J.
Venue: CA: A Cancer Journal for Clinicians
Publisher: Wiley
Published: 2009-05-27
Volume: 59
Issue: 4
Pages: 225-249
ISSN: 0007-9235 (ISSN-L)
DOI: 10.3322/caac.20006
OpenAlex: W2101995865
Cited by: 9,709
References: 15
Citations by year: 2026: 16 · 2025: 50 · 2024: 76 · 2023: 91 · 2022: 107 · 2021: 147 · 2020: 179 · 2019: 198 · 2018: 229 · 2017: 354 · 2016: 411 · 2015: 525 · 2014: 691 · 2013: 847 · 2012: 1176
FWCI: 963.18
Type: journal article
Language: en
Open access: gold
doi.org
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2288 d)
Locations: CA A Cancer Journal for Clinicians (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
Keywords: cancer incidence, cancer mortality, cancer survival, cancer projections, lung cancer, prostate cancer, colorectal cancer, breast cancer, cancer control, cancer prevention, early detection, racial and ethnic disparities, educational attainment, regional variation
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Ethnicity, Female, Humans, Male, Middle Aged, Neoplasms, Registries, Risk Factors, Sex Factors, United States, Incidence, Survival Analysis, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer Statistics, 2009

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks